SG Americas Securities’s Impax Laboratories, Inc. IPXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-50,604
Closed -$843K 3727
2017
Q4
$843K Sell
50,604
-42,276
-46% -$775K 0.01% 1500
2017
Q3
$1.89M Buy
92,880
+57,326
+161% +$1.1M 0.02% 836
2017
Q2
$572K Buy
+35,554
New +$525K 0.01% 1774
2016
Q4
Sell
-37,512
Closed -$889K 3658
2016
Q3
$889K Buy
+37,512
New +$1.01M 0.01% 1270
2016
Q2
Sell
-272,037
Closed -$8.71M 3208
2016
Q1
$8.71M Buy
272,037
+47,136
+21% +$1.66M 0.06% 237
2015
Q4
$9.62M Buy
224,901
+12,168
+6% +$486K 0.07% 228
2015
Q3
$7.49M Buy
212,733
+186,231
+703% +$8.39M 0.04% 280
2015
Q2
$1.22M Buy
26,502
+23,916
+925% +$1.14M 0.01% 976
2015
Q1
$121K Sell
2,586
-26,949
-91% -$1.07M ﹤0.01% 2161
2014
Q4
$936K Buy
29,535
+25,153
+574% +$736K ﹤0.01% 1251
2014
Q3
$104K Buy
+4,382
New +$112K ﹤0.01% 2360
2014
Q1
Sell
-6,240
Closed -$157K 2915
2013
Q4
$157K Sell
6,240
-16,486
-73% -$368K ﹤0.01% 2169
2013
Q3
$466K Buy
+22,726
New +$469K ﹤0.01% 1655

Other funds holding IPXL

SG Americas Securities's IPXL Position: Q1 2018 in Review

SG Americas Securities sold out of Impax Laboratories, Inc. (IPXL) in Q1 2018, closing a stake of 50,604 shares — an estimated $843K sold.

SG Americas Securities first reported a position in IPXL in Q3 2013 and held it in 13 quarters. The position peaked at $9.62M in Q4 2015. 188 funds tracked by Wall St. Rank hold IPXL as of Q1 2018.

  • SG Americas Securities reported no remaining Impax Laboratories, Inc. position as of Q1 2018 after selling out during the quarter.
  • SG Americas Securities sold 50,604 Impax Laboratories, Inc. shares in Q1 2018, an estimated $843K.
  • SG Americas Securities first reported a position in Impax Laboratories, Inc. in Q3 2013 and held it in 13 quarters.
  • SG Americas Securities's Impax Laboratories, Inc. position peaked at $9.62M in Q4 2015.
  • 188 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q1 2018.

Based on SG Americas Securities's 13F filing for Q1 2018, filed 3 May 2018.